Eli Lilly Canada reports Cymbalta, a drug they produce, has been approved for Osteoarthritis, an arthritis affecting almost everyone 65 years of age or older.
Osteoarthritis is the most common form of arthritis. In fact, one in eight Canadians live with it and almost everyone over 65 years of age has OA in at least one joint. Nearly 1 in 100 (or 300,000) Canadian adults (age 20+ years) have experienced at least moderate to severe pain due to OA.
Among all cases of OA, it is estimated that 40 per cent of patients have moderate to severe hip and/or knee OA.
Categories Medical Research